The virus enters through ACE2, an enzyme that is commonly found on the surface of lung cells and that, ordinarily, helps tamp down inflammation. When it’s interrupted, inflammatory forces run amok.
But ACE2 is far more than just an entryway for infection, and scientists say the enzyme could point the way to a much-needed treatment for Covid-19. Constant Therapeutics, a privately held Boston biotech company with a small staff and a threadbare website, hopes it might have just the drug to address that need.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,